Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4912-4917, Vol. 75, No. 10
Centro Nacional de Biología
Fundamental, Instituto de Salud Carlos III, Majadahonda 28220, Madrid,
Spain
Received 27 November 2000/Accepted 23 February 2001
The influenza A virus NEP (NS2) protein is an structural component
of the viral particle. To investigate whether this protein has an
effect on viral RNA synthesis, we examined the expression of an
influenza A virus-like chloramphenicol acetyltransferase (CAT) RNA in
cells synthesizing the four influenza A virus core proteins
(nucleoprotein, PB1, PB2, and PA) and NEP from recombinant plasmids.
Influenza A virus NEP inhibited drastically, and in a dose-dependent
manner, the level of CAT expression mediated by the recombinant
influenza A virus polymerase. This inhibitory effect was not observed
in an analogous artificial system in which expression of a synthetic
CAT RNA is mediated by the core proteins of an influenza B virus. This
result ruled out the possibility that inhibition of reporter gene
expression was due to a general toxic effect induced by NEP. Analysis
of the virus-specific RNA species that accumulated in cells expressing
the type A recombinant core proteins and NEP showed that there was an
important reduction in the levels of minireplicon-derived vRNA, cRNA,
and mRNA molecules. Taken together, the results obtained suggest a
regulatory role for NEP during virus-specific RNA synthesis, and this
finding is discussed regarding the biological implications for the
virus life cycle.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.10.4912-4917.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Influenza A Virus NEP (NS2 Protein) Downregulates
RNA Synthesis of Model Template RNAs

*
Corresponding author. Present address: División
de Productos Biológicos y Biotecnología, Agencia
Española del Medicamento, Crta. Majadahonda-Pozuelo km. 2, Majadahonda 28220, Madrid, Spain. Phone: 34-91-5967852. Fax:
34-91-5967892. E-mail: aportela{at}agemed.es.
Present address: Centro Nacional de Biotecnologia (CSIC), Campus de
Cantoblanco, 28049 Madrid, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|